-
1
-
-
0036161786
-
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: A systematic review
-
Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16(1): 51-60.
-
(2002)
Aliment Pharmacol Ther
, vol.16
, Issue.1
, pp. 51-60
-
-
Loftus Jr., E.V.1
Schoenfeld, P.2
Sandborn, W.J.3
-
2
-
-
33751560242
-
Psychotherapy with chronic inflammatory bowel disease patients: A review
-
Von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis. 2006;12(12): 1175-1184.
-
(2006)
Inflamm Bowel Dis
, vol.12
, Issue.12
, pp. 1175-1184
-
-
von Wietersheim, J.1
Kessler, H.2
-
3
-
-
51449101025
-
Crohn's disease: Current treatment options
-
Akobeng AK. Crohn's disease: current treatment options. Arch Dis Child. 2008;93(9):787-792.
-
(2008)
Arch Dis Child
, vol.93
, Issue.9
, pp. 787-792
-
-
Akobeng, A.K.1
-
4
-
-
72549100736
-
Strategies to improve quality of life in adolescents with inflammatory bowel disease
-
Karwowski CA, Keljo D, Szigethy E. Strategies to improve quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(11):1755-1764.
-
(2009)
Inflamm Bowel Dis
, vol.15
, Issue.11
, pp. 1755-1764
-
-
Karwowski, C.A.1
Keljo, D.2
Szigethy, E.3
-
5
-
-
84876015508
-
Management of inflammatory bowel disease in adults
-
Katz JA. Management of inflammatory bowel disease in adults. J Dig Dis. 2007;8(2):65-71.
-
(2007)
J Dig Dis
, vol.8
, Issue.2
, pp. 65-71
-
-
Katz, J.A.1
-
6
-
-
57249103566
-
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults
-
Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907-1913.
-
(2008)
Gastroenterology
, vol.135
, Issue.6
, pp. 1907-1913
-
-
Kappelman, M.D.1
Rifas-Shiman, S.L.2
Porter, C.Q.3
-
7
-
-
39749169727
-
The costs of Crohn's disease in the United States and other Western countries: A systematic review
-
Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J. The costs of Crohn's disease in the United States and other Western countries: a systematic review. Curr Med Res Opin. 2008;24(2):319-328.
-
(2008)
Curr Med Res Opin
, vol.24
, Issue.2
, pp. 319-328
-
-
Yu, A.P.1
Cabanilla, L.A.2
Wu, E.Q.3
Mulani, P.M.4
Chao, J.5
-
8
-
-
70949107842
-
Inflammatory bowel disease
-
Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009; 361(21):2066-2078.
-
(2009)
N Engl J Med
, vol.361
, Issue.21
, pp. 2066-2078
-
-
Abraham, C.1
Cho, J.H.2
-
9
-
-
0030954732
-
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
-
the Crohn's Disease cA2 Study Group
-
Targan SR, Hanauer SB, van Deventer SJH, et al; the Crohn's Disease cA2 Study Group. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med. 1997;337(15):1029-1035.
-
(1997)
N Engl J Med
, vol.337
, Issue.15
, pp. 1029-1035
-
-
Targan, S.R.1
Hanauer, S.B.2
van Deventer, S.J.H.3
-
10
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
-
and the ACCENT I Study Group
-
Hanauer SB, Feagan BG, Lichtenstein GR, et al; and the ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002:359(9317):1541-1549.
-
(2002)
Lancet
, vol.359
, Issue.9317
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
-
11
-
-
10744221312
-
Infliximab maintenance therapy for fistulizing Crohn's disease
-
Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350(9): 876-885.
-
(2004)
N Engl J Med
, vol.350
, Issue.9
, pp. 876-885
-
-
Sands, B.E.1
Anderson, F.H.2
Bernstein, C.N.3
-
12
-
-
0033529049
-
Infliximab for the treatment of fistulas in patients with Crohn's disease
-
Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340(18):1398-1405.
-
(1999)
N Engl J Med
, vol.340
, Issue.18
, pp. 1398-1405
-
-
Present, D.H.1
Rutgeerts, P.2
Targan, S.3
-
13
-
-
59749093368
-
Management of Crohn's disease in adults
-
and the Practice Parameters Committee of the American College of Gastroenterology
-
Lichtenstein GR, Hanauer SB, Sandborn WJ; and the Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2009;104(2):465-483.
-
(2009)
Am J Gastroenterol
, vol.104
, Issue.2
, pp. 465-483
-
-
Lichtenstein, G.R.1
Hanauer, S.B.2
Sandborn, W.J.3
-
14
-
-
17144388945
-
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease
-
Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005; 128(4):862-869.
-
(2005)
Gastroenterology
, vol.128
, Issue.4
, pp. 862-869
-
-
Lichtenstein, G.R.1
Yan, S.2
Bala, M.3
Blank, M.4
Sands, B.E.5
-
15
-
-
84886014245
-
Infliximab (Remicade) treatment results in lower hospitalization rate in Crohn's disease patients
-
Poster presented at, May 19-22, San Francisco, CA
-
Colombel JF, Rutgeerts P, Yan S, et al. Infliximab (Remicade) treatment results in lower hospitalization rate in Crohn's disease patients. Poster presented at Digestive Disease Week, May 19-22, 2002, San Francisco, CA.
-
(2002)
Digestive Disease Week
-
-
Colombel, J.F.1
Rutgeerts, P.2
Yan, S.3
-
16
-
-
82455188426
-
Long-term infliximab maintenance infusion regimens and rates of hospitalization, surgery and disability in Crohn's disease patients [Abstract]
-
A-589
-
Williams JB, Cross RK, Thameen D, et al. Long-term infliximab maintenance infusion regimens and rates of hospitalization, surgery and disability in Crohn's disease patients [Abstract]. Gastroenterology. 2005;128(4 Suppl 2):A-589.
-
(2005)
Gastroenterology
, vol.128
, Issue.4 SUPPL. 2
-
-
Williams, J.B.1
Cross, R.K.2
Thameen, D.3
-
17
-
-
73949129079
-
Long-term infliximab maintenance infusion regimens and rates of hospitalization, surgery, and disability in Crohn's disease [Abstract]
-
A-143
-
Williams JB, Weber LR, Beaulieu DB, et al. Long-term infliximab maintenance infusion regimens and rates of hospitalization, surgery, and disability in Crohn's disease [Abstract]. Gastroenterology. 2006;130(4 Suppl 2):A-143.
-
(2006)
Gastroenterology
, vol.130
, Issue.4 SUPPL. 2
-
-
Williams, J.B.1
Weber, L.R.2
Beaulieu, D.B.3
-
18
-
-
63849101007
-
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: Results from a single-centre cohort
-
Schnitzler F, Fidder H, Ferrante M, et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut. 2009;58(4):492-500.
-
(2009)
Gut
, vol.58
, Issue.4
, pp. 492-500
-
-
Schnitzler, F.1
Fidder, H.2
Ferrante, M.3
-
19
-
-
10744224387
-
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
-
Rutgeerts P, Feagan BG, Lichtenstein GR, et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology. 2004;126(2):402-413.
-
(2004)
Gastroenterology
, vol.126
, Issue.2
, pp. 402-413
-
-
Rutgeerts, P.1
Feagan, B.G.2
Lichtenstein, G.R.3
-
20
-
-
79956102354
-
-
PharMetrics Inc, Watertown, MA: IMS Health
-
PharMetrics Inc. LifeLink Health Plan Claims Database. Watertown, MA: IMS Health; 2010.
-
(2010)
LifeLink Health Plan Claims Database
-
-
-
21
-
-
0036719562
-
Patient adherence and medical treatment outcomes: A meta-analysis
-
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811.
-
(2002)
Med Care
, vol.40
, Issue.9
, pp. 794-811
-
-
DiMatteo, M.R.1
Giordani, P.J.2
Lepper, H.S.3
Croghan, T.W.4
-
22
-
-
1642397582
-
Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research
-
DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209.
-
(2004)
Med Care
, vol.42
, Issue.3
, pp. 200-209
-
-
DiMatteo, M.R.1
-
23
-
-
34250804375
-
Adherence to thiopurine treatment in out-patients with Crohn's disease
-
Bokemeyer B, Teml A, Roggel C, et al. Adherence to thiopurine treatment in out-patients with Crohn's disease. Aliment Pharmacol Ther. 2007;26(2):217-225.
-
(2007)
Aliment Pharmacol Ther
, vol.26
, Issue.2
, pp. 217-225
-
-
Bokemeyer, B.1
Teml, A.2
Roggel, C.3
-
24
-
-
34247597731
-
How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission?
-
Mantzaris GJ, Roussos A, Kalantzis C, Koilakou S, Raptis N, Kalantzis N. How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission? Inflamm Bowel Dis. 2007;13(4):446-450.
-
(2007)
Inflamm Bowel Dis
, vol.13
, Issue.4
, pp. 446-450
-
-
Mantzaris, G.J.1
Roussos, A.2
Kalantzis, C.3
Koilakou, S.4
Raptis, N.5
Kalantzis, N.6
-
25
-
-
33845197193
-
Persistence with pharmacotherapy for gastrointestinal disease: Associated costs of health care
-
Shaya FT, El Khoury AC, Wong W, et al. Persistence with pharmacotherapy for gastrointestinal disease: associated costs of health care. PT. 2006;31(11):657-665.
-
(2006)
PT
, vol.31
, Issue.11
, pp. 657-665
-
-
Shaya, F.T.1
El Khoury, A.C.2
Wong, W.3
-
26
-
-
58149094256
-
Systematic review: Impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares
-
Higgins PD, Rubin DT, Kaulback K, Schoenfield PS, Kane SV. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009;29(3):247-257.
-
(2009)
Aliment Pharmacol Ther
, vol.29
, Issue.3
, pp. 247-257
-
-
Higgins, P.D.1
Rubin, D.T.2
Kaulback, K.3
Schoenfield, P.S.4
Kane, S.V.5
-
27
-
-
40749086101
-
Medication non-adherence is associated with increased medical health care costs
-
Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008;53(4):1020-1024.
-
(2008)
Dig Dis Sci
, vol.53
, Issue.4
, pp. 1020-1024
-
-
Kane, S.1
Shaya, F.2
-
28
-
-
77949265473
-
Factors associated with non-adherence to oral medication for inflammatory bowel disease: A systematic review
-
Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2010;105(3):525-539.
-
(2010)
Am J Gastroenterol
, vol.105
, Issue.3
, pp. 525-539
-
-
Jackson, C.A.1
Clatworthy, J.2
Robinson, A.3
Horne, R.4
-
29
-
-
73949091371
-
Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients
-
Kane SV, Chao J, Mulani PM. Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients. Adv Ther. 2009;26(10):936-946.
-
(2009)
Adv Ther
, vol.26
, Issue.10
, pp. 936-946
-
-
Kane, S.V.1
Chao, J.2
Mulani, P.M.3
-
30
-
-
48549099538
-
Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis
-
Tang B, Rahman M, Waters HC, Callegari P. Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis. Clin Ther. 2008;30(7):1375-1384.
-
(2008)
Clin Ther
, vol.30
, Issue.7
, pp. 1375-1384
-
-
Tang, B.1
Rahman, M.2
Waters, H.C.3
Callegari, P.4
-
31
-
-
0033967019
-
The cost of hospitalization in Crohn's disease
-
Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalization in Crohn's disease. Am J Gastroenterol. 2000;95(2): 524-530.
-
(2000)
Am J Gastroenterol
, vol.95
, Issue.2
, pp. 524-530
-
-
Cohen, R.D.1
Larson, L.R.2
Roth, J.M.3
Becker, R.V.4
Mummert, L.L.5
-
32
-
-
0030730033
-
Inflammatory bowel disease: Health care and costs in Sweden in 1994
-
Blomqvist P, Ekbom A. Inflammatory bowel disease: health care and costs in Sweden in 1994. Scand J Gastroenterol. 1997;32(11):1134-1139.
-
(1997)
Scand J Gastroenterol
, vol.32
, Issue.11
, pp. 1134-1139
-
-
Blomqvist, P.1
Ekbom, A.2
-
33
-
-
0033993951
-
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital
-
Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastreoenterol. 2000;95(3):677-683.
-
(2000)
Am J Gastreoenterol
, vol.95
, Issue.3
, pp. 677-683
-
-
Bernstein, C.N.1
Papineau, N.2
Zajaczkowski, J.3
Rawsthorne, P.4
Okrusko, G.5
Blanchard, J.F.6
-
34
-
-
38049064973
-
Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004
-
Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007;13(12):1529-1535.
-
(2007)
Inflamm Bowel Dis
, vol.13
, Issue.12
, pp. 1529-1535
-
-
Nguyen, G.C.1
Tuskey, A.2
Dassopoulos, T.3
Harris, M.L.4
Brant, S.R.5
-
35
-
-
4644366980
-
Cost-of-illness of inflammatory bowel disease in the United Kingdom: A single-centre retrospective study
-
Bassi A, Dodd S, Williamson P, Bodger K. Cost-of-illness of inflammatory bowel disease in the United Kingdom: a single-centre retrospective study. Gut. 2004;53(10):1471-1478.
-
(2004)
Gut
, vol.53
, Issue.10
, pp. 1471-1478
-
-
Bassi, A.1
Dodd, S.2
Williamson, P.3
Bodger, K.4
-
36
-
-
38549098101
-
Medication compliance and persistence: Terminology and definitions
-
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44-47.
-
(2008)
Value Health
, vol.11
, Issue.1
, pp. 44-47
-
-
Cramer, J.A.1
Roy, A.2
Burrell, A.3
-
37
-
-
77953713861
-
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease
-
Stein DJ, Ananthakrishnan AN, Issa M, et al. Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease. Inflamm Bowel Dis. 2010;16(7): 1173-1179.
-
(2010)
Inflamm Bowel Dis
, vol.16
, Issue.7
, pp. 1173-1179
-
-
Stein, D.J.1
Ananthakrishnan, A.N.2
Issa, M.3
|